SECTOR : Biotech
ENTRY DATE : 2014
EXIT DATE : 2019
BUSINESS : Venture Capital
The leading pioneer in mobile diabetes management systems
Cellnovo, a company headquartered in London, provides a novel mobile system for managing type I diabetes. The Cellnovo system combines the benefits of a high-accuracy insulin patch pump, integrated activity monitor and a touchscreen, cellular enabled wireless handset with integrated blood glucose meter. The proprietary software is extremely easy to use and provides automatic connectivity to the cloud for real-time monitoring. The online data management system enables healthcare professionals to view clinical data in real time. This makes it a unique system enabling diabetics to lead a normal active life while keeping a close eye on their glycaemia, insulin use, activity and food intake.